{"id":"W2899175992","doi":"10.1182/blood-2018-99-118828","title":"Brentuximab Vedotin Plus Chemotherapy in Patients with Advanced-Stage Classical Hodgkin Lymphoma (cHL): Evaluation of Modified Progression-Free Survival (mPFS) and Traditional PFS in the Phase 3 ECHELON-1 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Internal medicine; Medicine; Classical Hodgkin lymphoma; Oncology; Chemotherapy; Progression-free survival; Chemotherapy regimen; Hodgkin lymphoma; Overall survival; Lymphoma; Stage (stratigraphy); Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026871,0.0005111222,0.001057002,0.0002543886,0.0001639888,0.0006635418,0.0005096464,0.000499756,0.0009706897],"category_scores_gemma":[0.001348875,0.0002256161,0.001123475,0.0003511995,0.0003187335,0.0006297067,0.000403149,0.00114279,0.0001672507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006338503,"about_ca_system_score_gemma":0.0006925294,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006570886,"about_ca_topic_score_gemma":0.001632728,"domain_scores_codex":[0.9992873,0.0004713917,0.00003506563,0.00007722998,0.0000761001,0.00005295823],"domain_scores_gemma":[0.9988952,0.0002899338,0.0003360747,0.00006635583,0.00006267706,0.0003498532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7362864,0.009506252,0.14111,0.001087192,0.00546451,0.0001341121,0.0002023597,0.002484586,0.006518201,0.000159665,0.001461006,0.09558569],"study_design_scores_gemma":[0.2226538,0.3943782,0.3657053,0.00018003,0.005723326,0.0004459469,0.0001515732,0.004828074,0.002191468,0.0004338519,0.003256853,0.00005156931],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995317,0.00346829,0.0001402456,0.000121584,0.00003139055,0.0002199329,0.0002723746,0.00001415037,0.0004148694],"genre_scores_gemma":[0.9979139,0.0007934913,0.0002658934,0.0001782287,0.00006059236,0.0001549856,0.0004576452,0.000003135919,0.0001720917],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0026871,"threshold_uncertainty_score":0.01421088,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04121726497175998,"score_gpt":0.326195023048547,"score_spread":0.284977758076787,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}